Plasma periostin as a biomarker of osteoporosis in postmenopausal women with type 2 diabetes.

Junyan LiXiaohong NiuQinqin SiQi SongMiaomiao JinRuijun ZhouYan SunJianbo LiQingzhong Wang

Published in: Journal of bone and mineral metabolism (2021)

The current study demonstrated that plasma periostin levels were significantly associated with BMD in patients with T2DM, and periostin might act as a novel biochemical marker of osteoporosis in postmenopausal women with type 2 diabetes.

Keyphrases

postmenopausal women
bone mineral density
type diabetes
adipose tissue
skeletal muscle
glycemic control
body composition
weight loss